A recent trial of 505 patients with iron deficiency or anaemia undergoing cardiac surgery investigated the effects of ultra short-term treatment using a combination of iron, erythropoietin, vitamin B12, and folic acid. This evidence concerns the gene EPO and Iron deficiency anemia.